1-Hexanol

1-Hexanol

SCHEMBL2118314

CC(C)C(=O)O.CCCCCCO

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.62
ALDH1A1 P00352 3/20 0.62
LMNA P02545 2/20 0.62
HSD17B10 Q99714 2/20 0.62
MEN1 O00255 2/20 0.62
KMT2A Q03164 2/20 0.62
SMN1; SMN2 Q16637 1/20 0.57
GPR84 Q9NQS5 6/20 0.50
FFAR1 O14842 2/20 0.50
ACE2 Q9BYF1 1/20 0.50
PPARD Q03181 6/20 0.48
MAPT P10636 1/20 0.48
LCK P06239 1/20 0.48
ZDHHC20 Q5W0Z9 1/20 0.48
ZDHHC2 Q9UIJ5 1/20 0.48
PPARG P37231 5/20 0.46
PPARA Q07869 5/20 0.46
HDAC11 Q96DB2 4/20 0.46
TLR2 O60603 2/20 0.46
TDP1 Q9NUW8 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1-Hexanol SCHEMBL6112469 1.00 TSHR (0.62) TSHRALDH1A1LMNAHSD17B10MEN1
1,6-Hexanediol SCHEMBL8420383 0.90 GPR84 (0.50) TSHRALDH1A1LMNAHSD17B10MEN1
1,6-Hexanediol SCHEMBL8421542 0.90 GPR84 (0.50) TSHRALDH1A1LMNAHSD17B10MEN1
Pentadecane SCHEMBL28168073 0.90 GPR84 (0.58) TSHRALDH1A1HSD17B10MEN1KMT2A
Heptane SCHEMBL28164569 0.90 GPR84 (0.58) TSHRALDH1A1HSD17B10MEN1KMT2A
Octane SCHEMBL28234048 0.90 GPR84 (0.58) TSHRALDH1A1HSD17B10MEN1KMT2A
Lactic Acid SCHEMBL29116772 0.88 LMNA (0.59) TSHRALDH1A1LMNAHSD17B10MEN1
Cetostearyl Alcohol SCHEMBL28027646 0.88 LMNA (0.59) TSHRALDH1A1LMNAHSD17B10MEN1
1-Hexanol SCHEMBL27745635 0.88 LMNA (0.59) TSHRALDH1A1LMNAHSD17B10MEN1
Myristyl Alcohol SCHEMBL27503558 0.88 LMNA (0.59) TSHRALDH1A1LMNAHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4001367-B1 AQUEOUS INKJET INK COMPOSITIONS MADE FROM HIGH VISCOSITY LATEXES XEROX CORP (US) 2026-01-07 EP disclosed
EP-4124639-B1 INK COMPOSITION WITH PH RESPONSIVE RESIN PARTICLES XEROX CORP (US) 2025-12-24 EP disclosed
US-12129323-B2 High viscosity latexes XEROX CORPORATION (US) 2024-10-29 US disclosed
US-12110402-B2 Aqueous inkjet ink compositions made from high viscosity latexes XEROX CORPORATION (US) 2024-10-08 US disclosed
US-12043678-B2 Monodisperse latexes XEROX CORPORATION (US) 2024-07-23 US disclosed
US-11952451-B2 Latexes with pH responsive resin particles XEROX CORPORATION (US) 2024-04-09 US disclosed
US-11834580-B2 Ink composition with pH responsive resin particles XEROX CORPORATION (US) 2023-12-05 US disclosed
US-11781025-B2 Aqueous inkjet ink compositions XEROX CORPORATION (US) 2023-10-10 US disclosed
US-11746249-B2 Polyvinyl chloride aggregate particles, method for producing the same, composition for metal can coating material, composition for marking film, and coating film KANEKA CORPORATION (JP) 2023-09-05 US disclosed
US-11708504-B2 Aqueous inkjet ink compositions made from monodisperse latexes XEROX CORPORATION (US) 2023-07-25 US disclosed
US-20130310288-A1 KETAL COMPOUNDS AND USES THEREOF SEGETIS, INC. (US) 2013-11-21 US disclosed
US-20120122745-A1 KETAL COMPOUNDS AND USES THEREOF SEGETIS, INC. (US) 2012-05-17 US disclosed
EP-2445894-A1 KETAL COMPOUNDS AND USES THEREOF Segetis, Inc. (US) 2012-05-02 EP disclosed
US-20120095176-A1 Process for the production of a polyvinyl-chloride (PVC) resin VINNOLIT GMBH & CO. KG (DE) 2012-04-19 US disclosed
WO-2010151558-A1 KETAL COMPOUNDS AND USES THEREOF SEGETIS, INC. (US) 2010-12-29 WO disclosed
US-5087664-A Vinyl chloride polymer, plasticizer, adhesion imparting agent of aromatic diisocyanate polymer blocked with oxybenzoic acid ester MITSUBISHI KASEI VINYL COMPANY (JP) 1992-02-11 US disclosed
US-5030673-A Vinyl chloride polymer, plasticizer and adhesion imparting aromatic diisocyanate polymer MITSUBISHI KASEI VINYL COMPANY (JP) 1991-07-09 US disclosed
EP-0214495-B1 PLASTISOL COMPOSITION, UNDERCOATING AND BLOCKED POLYISOCYANURATE MITSUBISHI KASEI VINYL COMPANY (JP) 1991-01-02 EP disclosed
US-4839218-A MULTILAYER; CONTAINING A VINYL CHLORIDE PLASTISOL AND ADHESIVE MITSUBISHI KASEI VINYL COMPANY (JP) 1989-06-13 US disclosed
EP-0214495-A2 Plastisol composition, undercoating and blocked polyisocyanurate MITSUBISHI KASEI VINYL COMPANY (JP) 1987-03-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130310288-A1 KETAL COMPOUNDS AND USES THEREOF KARS1, PKLR, PHYKPL TSHR 4580/4885ALDH1A1 1817/4885LMNA 2234/4885
US-20120122745-A1 KETAL COMPOUNDS AND USES THEREOF KARS1, PKLR, KYAT1 TSHR 4564/4885ALDH1A1 1647/4885LMNA 2578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.